Lymphoma
Showing NaN - NaN of 94
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Lymphoma Trial in United States (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- rituximab
- +5 more
-
Anchorage, Alaska
- +258 more
Sep 23, 2022
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)
Completed
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
-
Tucson, Arizona
- +422 more
Aug 16, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma Trial in Worldwide (BMS-986403, Fludarabine, Cyclophosphamide)
Recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma
- BMS-986403
- +2 more
-
Birmingham, Alabama
- +24 more
Jul 6, 2022
Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)
Completed
- Lymphoma
- Acute Lymphoblastic Leukemia
- Apixaban
- No systemic anticoagulant prophylaxis
-
Phoenix, Arizona
- +95 more
Feb 10, 2022
Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)
Active, not recruiting
- Lymphoma
- Leukemia, Lymphocytic, Chronic, B-Cell
- Durvalumab
- +4 more
-
Gilbert, Arizona
- +53 more
Jan 25, 2022
Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)
Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
-
Birmingham, Alabama
- +38 more
Oct 25, 2021
Lymphoma Trial in United States (ACTR707, rituximab)
Terminated
- Lymphoma
- ACTR707
- rituximab
-
Gilbert, Arizona
- +10 more
Oct 4, 2021
Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Leukemia
- Lymphoma
- rituximab
- +7 more
-
Duarte, California
- +24 more
Aug 16, 2021
Kidney Cancer, Leukemia, Lymphoma Trial in United States (glutamic acid, )
Completed
- Kidney Cancer
- +5 more
- glutamic acid
- placebo
-
Fort Myers, Florida
- +5 more
Jul 22, 2021
Adult Solid Tumor, Lymphoma Trial in United States (Geriatric Assessment Summary, Geriatric Assessment Targeted Recommendations,
Completed
- Adult Solid Neoplasm
- Lymphoma
- Geriatric Assessment Summary
- +2 more
-
Duarte, California
- +18 more
Oct 15, 2020
Lymphoma Trial in United States (biological, drug, genetic)
Completed
- Lymphoma
- rituximab
- +7 more
-
La Jolla, California
- +16 more
Aug 7, 2020